Donald M. Jensen - Concepedia

Author

Donald M. Jensen

Also Known As

D Jensen, D M Jensen, D. Jensen, D. M. Jensen, DONALD M. JENSEN, Donald Jensen, Donald M Jensen, Donald M. Jensen, Guadalupe Garcia-Tsao, Jensen, Donald M.

193

Publications

6.8K

Citations

H-Index

Concepts

All Affiliations

Rush University Medical Center University of Chicago University of Chicago Medical Center Presbyterian St. Luke's Medical Center Roche (Switzerland)

About

Donald M. Jensen is an author at Rush University Medical Center specializing in medicine, hepatitis, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	1.2K
2	Public Health	3	3	98
3	Health Sciences	2	2	203
4	Engineering	1	1	14
5	Clinical Nutrition	1	1	61

Donald M. Jensen

Publications

5.1K

Citations

H-Index

Page 1

	Year	Citations
Retreatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin Stefan Zeuzem, Ira M. Jacobson, Tolga Baykal, New England Journal of Medicine	2014	514
Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapy Donald M. Jensen, Timothy R. Morgan, Patrick Marcellin, Hepatology	2006	469
Efficacy and Safety of Pegylated (40–Kd) Interferon α–2A Compared With Interferon α–2A in Noncirrhotic Patients With Chronic Hepatitis C K. Rajender Reddy, Teresa L. Wright, Paul J. Pockros, Hepatology	2001	360
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial Eric Lawitz, Jay Lalezari, Tarek Hassanein, The Lancet Infectious Diseases HepatologyHepatitis CGenotypes 1Viral HepatitisAntiviral Drug Development	2013	328
Predictive value of <scp>ALT</scp> levels for non‐alcoholic steatohepatitis (<scp>NASH</scp>) and advanced fibrosis in non‐alcoholic fatty liver disease (<scp>NAFLD</scp>) Siddharth Verma, Donald M. Jensen, John Hart, Liver International	2013	311
Detection of Antibodies Directed against a Liver-Specific Membrane Lipoprotein in Patients with Acute and Chronic Active Hepatitis Donald M. Jensen, Ian G. McFarlane, B Portmann, New England Journal of Medicine	1978	253
Treatment of chronic hepatitis C with consensus interferon: A multicenter, randomized, controlled trial Myron J. Tong, K. Rajender Reddy, W M Lee, Hepatology	1997	181
Re-treatment of Patients With Chronic Hepatitis C Who Do Not Respond to Peginterferon-α2b Donald M. Jensen Annals of Internal Medicine	2009	172
Influence of ethnicity on histological differences in non-alcoholic fatty liver disease Smruti R. Mohanty, Tara N. Troy, Dezheng Huo, Journal of Hepatology ObesityMetabolic SyndromeMetabolic Associated SteatohepatitisBody CompositionHepatology	2009	142
Mechanism of action of ribavirin in the treatment of chronic hepatitis C. Helen S. Te, Glenn Randall, Donald M. Jensen PubMed	2007	122

Page 1